Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-03-10 @ 7:23 PM
Study NCT ID:
NCT00037518
Status:
COMPLETED
Last Update Posted:
2013-05-08
First Post:
2002-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
Sponsor:
Amgen
Organization:
Study Overview
Official Title:
An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism.
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess an investigational medication for patients with severe primary hyperparathyroidism or parathyroid cancer.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: